(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)], MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-448) [VH (HOMO SAPIENS IGHV1-46*01 (76.5%) -(IGHD) -IGHJ6*03 (90.9%)) [8.8.11] (1-118) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 (CH1 R120>K (215) (119-216), HINGE (217-231), CH2 L1.3>A (235), L1.2>A (236) (232-341), CH3 E12 (357), M14 (359) (342-446), CHS (447-448)) (119-448)], (221-219')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-219') [V-KAPPA (MUS MUSCULUS IGKV1-117*01 (89.0%)/HOMO SAPIENS IGKV2-28*01 OR IGKV2-29*02 (85.0%) - HOMO SAPIENS IGKJ2*01 (100%)) [11.3.9] (1'-112') -HOMO SAPIENS IGKC*01, KM3 A45.1 (158), V101 (196) (113'-219')]; DIMER (227-227":230-230")-BISDISULFIDE. PROPOSED INN: LIST 119(WHO)
BUDIGALIMABUM(INN)